房性心律失常合并心力衰竭患者资源利用与结局的性别差异
女性年龄更大、合并症不同,接受导管消融更少(12.0% vs 20.7%),住院更长,院内死亡率更高(1.6% vs 0.9%)。校正年龄和合并症后,性别非院内死亡的独立预测因子。
要点
- 女性房颤合并心衰患者接受导管消融的比例显著低于男性(12.0% vs 20.7%)。
- 女性住院时间更长(6.6±5.8 vs 5.2±5.2天),院内死亡率更高(1.6% vs 0.9%)。
- 校正年龄和合并症后,性别不是院内死亡的独立预测因子(OR 0.96,95%CI 0.82-1.12,p=0.579)。
核心结论
- 房颤合并心衰患者在人口学、资源利用和院内结局方面存在性别差异,治疗女性时需考虑这些差异以促进充分的知情决策。
主要发现
- 女性占46.2%,年龄显著大于男性(75.4±9.5 vs 68.7±11.1岁,p<0.001)。
- 女性脑血管病(2.4% vs 1.8%)、痴呆(5.3% vs 2.2%)、风湿病(2.1% vs 0.8%)、糖尿病伴慢性并发症(9.7% vs 9.1%)、偏瘫或截瘫(1.7% vs 1.2%)、慢性肾病(43.7% vs 33.5%)比例更高。
- 女性心肌梗死(5.4% vs 10.5%)、外周血管病(6.9% vs 11.3%)、轻度肝病(2.0% vs 2.3%)、任何恶性肿瘤(1.0% vs 1.3%)比例更低。
- 女性接受导管消融更少(12.0% vs 20.7%,p<0.001),住院更长(6.6±5.8 vs 5.2±5.2天,p<0.001),院内死亡率更高(1.6% vs 0.9%,p<0.001)。
- 在导管消融患者中,女性血管入路并发症需干预(4.8% vs 4.2%,p=0.001)和心包填塞(0.3% vs 0.1%,p<0.001)更常见,而卒中(0.6% vs 0.5%,p=0.179)和死亡(0.3% vs 0.1%,p=0.101)无性别差异。
临床怎么用
- 治疗女性房颤合并心衰患者时,应考虑其年龄更大、合并症负担不同及导管消融使用率较低的特点。
- 临床决策中需关注女性住院时间更长和院内死亡率更高的趋势,并促进充分的患者知情决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Atrial fibrillation or atrial flutter (AF) and heart failure (HF) often go hand in hand and, in combination, lead to an increased risk of death compared with patients with just one of both entities. Sex-specific differences in patients with AF and HF are under-reported. Therefore, the aim of this study was to investigate sex-specific catheter ablation (CA) use and acute in-hospital outcomes in patients with AF and concomitant HF in a retrospective cohort study. METHODS: Using International Statistical Classification of Diseases and Related Health Problems and Operations and Procedures codes, administrative data of 75 hospitals from 2010 to 2018 were analysed to identify cases with AF and HF. Sex differences were compared for baseline characteristics, right and left atrial CA use, procedure-related adverse outcomes and in-hospital mortality. RESULTS: Of 54 645 analysed cases with AF and HF, 46.2% were women. Women were significantly older (75.4±9.5 vs 68.7±11.1 years, p<0.001), had different comorbidities (more frequently: cerebrovascular disease (2.4% vs 1.8%, p<0.001), dementia (5.3% vs 2.2%, p<0.001), rheumatic disease (2.1% vs 0.8%, p<0.001), diabetes with chronic complications (9.7% vs 9.1%, p=0.033), hemiplegia or paraplegia (1.7% vs 1.2%, p<0.001) and chronic kidney disease (43.7% vs 33.5%, p<0.001); less frequently: myocardial infarction (5.4% vs 10.5%, p<0.001), peripheral vascular disease (6.9% vs 11.3%, p<0.001), mild liver disease (2.0% vs 2.3%, p=0.003) or any malignancy (1.0% vs 1.3%, p<0.001), underwent less often CA (12.0% vs 20.7%, p<0.001), had longer hospitalisations (6.6±5.8 vs 5.2±5.2 days, p<0.001) and higher in-hospital mortality (1.6% vs 0.9%, p<0.001). However, in the multivariable generalised linear mixed model for in-hospital mortality, sex did not remain an independent predictor (OR 0.96, 95% CI 0.82 to 1.12, p=0.579) when adjusted for age and comorbidities. Vascular access complications requiring interventions (4.8% vs 4.2%, p=0.001) and cardiac tamponade (0.3% vs 0.1%, p<0.001) occurred more frequently in women, whereas stroke (0.6% vs 0.5%, p=0.179) and death (0.3% vs 0.1%, p=0.101) showed no sex difference in patients undergoing CA. CONCLUSIONS: There are sex differences in patients with AF and HF with respect to demographics, resource utilisation and in-hospital outcomes. This needs to be considered when treating women with AF and HF, especially for a sufficient patient informed decision making in clinical practice.
引用
- Ueberham L, König S, Hohenstein S, et al. Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure. Heart. 2019. PMID: 31857353. doi:10.1136/heartjnl-2019-315566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。